Navigation Links
UCLA-industry partnership to develop, commercialize new nanotechnology
Date:12/17/2007

The California NanoSystems Institute (CNSI) at UCLA and NanoPacific Holdings Inc. have announced a partnership to commercialize a mechanized, nanoparticle-based technology that could lead to prolonged lives of enhanced quality for millions of cancer sufferers.

Under the terms of the partnership, NanoPacific will receive exclusive license to key intellectual property owned by UCLA and developed at the CNSI's Nano Machine Center. The newly formed company will provide funding for further research at the center to broaden the scope of the technology for a diverse range of applications.

"This partnership is a prime example of how the CNSI will fulfill its mission," said UCLA Chancellor Gene Block. "Working with industry to bring new developments in technology and biotechnology into the marketplace for the benefit of the people of California is exactly why the CNSI was established."

The first application under the new partnership will involve the use of the technology for the targeted delivery of Food and Drug Administration-approved chemotherapeutic agents to cancer cells. Because of their unique properties, the mechanized nanoparticles can be preprogrammed to seek out cancer cells specifically while avoiding the body's other rapidly growing cells. In addition, the robot-like nanoparticles allow for the triggered release of cancer drugs that are currently difficult to administer intravenously because of their low solubilities in the blood stream.

The delivery mechanism consists of porous nanoparticles that are capable of storing and selectively releasing small drug molecules via nanoscale gates that can be opened and closed at will on the particles' surfaces. In this way, drugs can be loaded and unloaded in a selective manner in different environments. By equipping the nanoparticle surfaces with specific tags to preferentially target cancer cells, diseased cells can be destroyed selectively without affecting healthy ones, reducing drug toxicity dramatically and sparing patients many of the highly undesirable side effects of chemotherapy, including hair loss and chronic diarrhea.

The concept is a simple one that is open to infinite variation, and significant applications of the new technology are anticipated in other major commercial areas, including scents and cosmetics, food products, environmental remediation, construction materials, and defense.

The California NanoSystems Institute fosters interdisciplinary collaborations in nanoscience and nanotechnology research and facilitates partnerships with private industry, fueling economic development and ensuring the social well-being of California, the United States and the world.

"This collaboration underscores many key objectives of the CNSI," said Leonard H. Rome, CNSI interim director and senior associate dean of research at the David Geffen School of Medicine at UCLA. "The faculty members involved in the Nano Machine Center at CNSI are developing exciting technologies which have the potential to generate major advances in healthcare and medical treatment."

"We are looking forward to launching this collaboration and working in a seamless fashion with UCLA and the world-class scientific team at the CNSI to develop and commercialize nanotechnology," said Joseph A. Boystak, chairman and co-chief executive officer of NanoPacific Holdings. "We intend to prioritize and aggressively pursue multiple applications in the medical, consumer, environmental and industrial sectors, and in doing so, we envision spawning a series of companies and partnerships with important commercial partners to accelerate the roll-out of this technology."

"I am delighted to be part of the team that provides a bridge from the cutting-edge research being done at the CNSI to industry," said Michael B. Flesch, vice chairman and co-CEO of NanoPacific. "This step is a profound one for NanoPacific Holdings and UCLA as we move forward in the dynamic world of nanotechnology. This collaboration also underscores the value and importance of academic-commercial partnerships."

"The breadth of commercial applications for technologies arising from university nanotechnology research is enormous, and UCLA is excited to be working with the team of business and scientific talent at NanoPacific to bring nanotech-enabled products to market to benefit patients and society at large," said Earl Weinstein, assistant director of technology transfer at UCLA. "This startup is part of a growing number of high-tech companies resulting from research at UCLA that have chosen to establish themselves locally, which also benefits the burgeoning Los Angeles tech cluster.

"We look forward to a long and productive relationship with them," he said.


'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Related medicine news :

1. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
2. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
3. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
4. B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership
5. NASN Joins Partnership to Fight Chronic Disease
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
8. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
9. Partnership to Fight Chronic Disease Announces Ideas for Change in Health Care
10. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
11. Anthem Blue Cross and Blue Shield Partnership Plan Wins Nevada Immunization Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... Dallas, Texas (PRWEB) , ... February 07, 2016 ... ... its new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and ... , MyDecision™ combines three elements to cut the cost of providing employee healthcare ...
(Date:2/6/2016)... ... 2016 , ... Shark Finds and Kevin Harrington, along with the ... campaign with Belly Bands. , Having a dog is great—except when it wets every ... find nothing works, get Belly Bands, the easiest way to stop dogs from ...
(Date:2/5/2016)... Lake City, UT (PRWEB) , ... February 05, 2016 , ... ... Activz Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist ... Cool Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV ...
(Date:2/5/2016)... ... 05, 2016 , ... Looking for a last-minute Valentine’s Day gift for the ... toes. Foot massage, whether administered by a professional masseuse or a loved one, can ... Board of Multiple Specialties in Podiatry (ABMSP) has taken the upcoming Valentine’s Day ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... independent PROSHRED franchises from across the country gathered at the La Valencia Hotel ... top performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Ala. , Feb. 5, 2016  Patients in ... high intensity focused ultrasound (HIFU) therapy no longer have to ... to announce its partnership with Urology Centers of Alabama ... the newly FDA-cleared procedure for qualifying patients. ... their expertise in the treatment of prostate cancer using many ...
(Date:2/5/2016)... --> --> ... the global active pharmaceuticals ingredients (APIs) market stood at ... US$185.9 bn by 2020. It is expected to expand ... The title of the report is "Active Pharmaceutical Ingredients ... by Therapeutic Area) - Global Industry Analysis, Size, Share, ...
(Date:2/5/2016)... HARROGATE, England , February 5, 2016 ... --> Today, VoicePower Ltd - The Speech Recognition People, ... has been deployed to improve patient care, reduce turnaround times and ... ,- Wirral CCG ,- VoicePower client since 2013 Challenge: ... Challenge: --> - Six doctors ,- Wirral ...
Breaking Medicine Technology: